Icure Pharmaceutical Incorporation (175250) Price & Analysis

― Followers

175250 Stock Chart & Stats

$1791.00

$1.00(0.06%)

Sep 09, 2026

―

Day’s Range― - ―

52-Week Range$1,661.00 - $3,300.00

Previous CloseN/A

VolumeN/A

Average Volume (3M)209.61K

Market Cap

₩66.89B

Enterprise Value$99.33K

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.12

Next Earnings

Nov 12, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)61.97

Shares Outstanding37,558,370

10 Day Avg. Volume628,829

30 Day Avg. Volume209,609

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

Icure Pharmaceutical Incorporation News

Icure’s Largest Shareholder Pledges Entire 30% Stake as KRW 28 Billion Loan Collateral

Icure Pharmaceutical Incorporation ( ($KR:175250) ) has shared an update. Icure Pharmaceutical’s largest shareholder, Solum Cosmetic Co., Ltd.,...

7d ago

Icure Pharmaceutical Shares to Resume Trading on KOSDAQ After Listing Review

Icure Pharmaceutical Incorporation ( ($KR:175250) ) just unveiled an update. Icure Pharmaceutical Incorporation announced that trading in its...

8d ago

175250 FAQ

What was Icure Pharmaceutical Incorporation’s price range in the past 12 months?

Icure Pharmaceutical Incorporation lowest stock price was $1661.00 and its highest was $3300.00 in the past 12 months.

What is Icure Pharmaceutical Incorporation’s market cap?

Icure Pharmaceutical Incorporation’s market cap is ₩66.89B.

When is Icure Pharmaceutical Incorporation’s upcoming earnings report date?

Icure Pharmaceutical Incorporation’s upcoming earnings report date is Nov 12, 2026 which is in 63 days.

How were Icure Pharmaceutical Incorporation’s earnings last quarter?

Icure Pharmaceutical Incorporation released its earnings results on Aug 14, 2026. The company reported $61.966 earnings per share for the quarter.

Is Icure Pharmaceutical Incorporation overvalued?

According to Wall Street analysts Icure Pharmaceutical Incorporation’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Icure Pharmaceutical Incorporation pay dividends?

Icure Pharmaceutical Incorporation does not currently pay dividends.

What is Icure Pharmaceutical Incorporation’s EPS estimate?

Icure Pharmaceutical Incorporation’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Icure Pharmaceutical Incorporation have?

Icure Pharmaceutical Incorporation has 37,558,370 shares outstanding.

What happened to Icure Pharmaceutical Incorporation’s price movement after its last earnings report?

Icure Pharmaceutical Incorporation reported an EPS of $61.966 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Icure Pharmaceutical Incorporation?

Currently, no hedge funds are holding shares in KR:175250

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology